BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7270495)

  • 1. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
    Langley JW; Spiva D; Hendren D; Orrell J
    Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plateletapheresis program. II. Computer selection of HLA compatible donors.
    Jorgensen DW; McFarland JG; Hillman RS; Slichter SJ
    Transfusion; 1984; 24(4):292-8. PubMed ID: 6547791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet collection using the IBM 2997 cell separator.
    Bond R; Wood L; Jacobs P; Kernoff LM
    J Clin Apher; 1985; 2(3):258-61. PubMed ID: 4030712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model to determine required pool size for HLA-typed community donor apheresis programs.
    Bolgiano DC; Larson EB; Slichter SJ
    Transfusion; 1989 May; 29(4):306-10. PubMed ID: 2718233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing yield of plateletpheresis using intermittent flow cell separator.
    DAS SS; Chaudhary RK; Shukla JS
    Clin Lab Haematol; 2005 Oct; 27(5):316-9. PubMed ID: 16178912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India.
    Pandey P; Tiwari AK; Sharma J; Singh MB; Dixit S; Raina V
    Transfus Apher Sci; 2012 Apr; 46(2):163-7. PubMed ID: 22365925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
    Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
    Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat plateletpheresis: the effects on the donor and the yield.
    Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
    Vox Sang; 1992; 63(2):102-6. PubMed ID: 1441301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudothrombocytopenia in plateletpheresis donors.
    Sweeney JD; Holme S; Heaton WA; Campbell D; Bowen ML
    Transfusion; 1995 Jan; 35(1):46-9. PubMed ID: 7998068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor platelet response and product quality assurance in plateletpheresis.
    Lasky LC; Lin A; Kahn RA; McCullough J
    Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical review of platelet yield by Haemonetics 30 . Based on literature and own observations.
    Rosenkvist J; Holsøe E; Freiesleben E; Sørensen H
    Scand J Haematol; 1980 Aug; 25(2):165-70. PubMed ID: 7466305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Analysis of Various Aspects of Plateletpheresis on the Fenwal Amicus and Fresenius COM.TEC Cell Separator Instruments.
    Philip J; Biswas AK; Chatterjee T; Mallhi RS
    Lab Med; 2014; 45(4):315-23. PubMed ID: 25316663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plateletpheresis-induced increase in platelet reactivity using different cell separators.
    Jung F; Bläsi U; Radtke H; Mrowietz C; Pindur G; Kiesewetter H; Wenzel E
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):237-43. PubMed ID: 7496123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.